Ticlopidine prevents renal disease progression in rats with reduced renal mass
- 1 March 1990
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 37 (3) , 934-942
- https://doi.org/10.1038/ki.1990.68
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Mesangial cells express PDGF mRNAs and proliferate in response to PDGFAmerican Journal of Physiology-Renal Physiology, 1988
- The Role of Hemodynamic Factors in the Initiation and Progression of Renal DiseaseJournal of Urology, 1985
- Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation.Proceedings of the National Academy of Sciences, 1985
- Role of heparin as a protective agent following reduction of renal massKidney International, 1984
- Ticlopidine: A Promise for the Prevention and Treatment of Thrombosis and Its ComplicationsPathophysiology of Haemostasis and Thrombosis, 1983
- Inhibition by anticoagulant drugs of the progressive hypertension and uremia associated with renal infarction in ratsThrombosis Research, 1982
- Effect of ticlopidine on human platelet responsiveness ex vivo: Comparison with aspirinThrombosis Research, 1980
- Ticlopidine - An antiplatelet drug: Effects in human volunteersThrombosis Research, 1978
- Pharmacological Evaluation of Ticlopidine, A Novel Inhibitor of Platelet FunctionPublished by Georg Thieme Verlag KG ,1977
- Pathogenesis of the glomerulopathy associated with renal infarction in ratsKidney International, 1976